Vijaya Diagnostic Centre Shows Positive Growth in Q1 Financial Results

Vijaya Diagnostic Centre, a midcap healthcare services company, has recently announced its financial results for the quarter ended March 2024. The company has shown a positive performance in this quarter, with its score improving from 7 to 19 in the last 3 months. One of the key factors contributing to this improvement is the company's ability to manage interest payments, with the Operating Profit to Interest ratio being the highest at 10.20 times in the last five quarters. This indicates that the company's financial health is improving. In terms of sales, Vijaya Diagnostic Centre has also shown a positive trend, with the net sales for this quarter being the highest at Rs 155.21 crore in the last five quarters. This is a growth of 20.9% over the average net sales of the previous four quarters. This indicates a positive near-term sales trend for the company. The company's operating profit (PBDIT) for this quarter is also the highest at Rs 63.12 crore in the last five quarters, showing a positive trend. Similarly, the profit before tax (PBT) has also shown a positive trend, with the highest PBT of Rs 40.62 crore in the last five quarters. This is a growth of 23.8% over the average PBT of the previous four quarters. The profit after tax (PAT) for this quarter is also the highest at Rs 33.45 crore in the last five quarters, indicating a positive trend in the company's profitability. The earnings per share (EPS) for this quarter is also the highest at Rs 3.27, showing an increase in profitability and creating higher earnings for shareholders. Based on these financial results, MarketsMOJO has given a 'Hold' call for Vijaya Diagnostic Centre's stock. With a positive trend in its financial performance, the company is on track for growth and success in the healthcare services industry.